MYRIAD GENETICS, INC. (MYGN) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $1.00M; Additional Paid in Capital, Common StockUSD $1.50B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $800.00K; Retained Earnings (Accumulated Deficit)USD $-1.20B.
- 2026-03-31: Common Stock, Value, IssuedUSD $900.00K; Additional Paid in Capital, Common StockUSD $1.49B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $700.00K; Retained Earnings (Accumulated Deficit)USD $-1.16B.
- 2025-12-31: Common Stock, Value, IssuedUSD $900.00K; Additional Paid in Capital, Common StockUSD $1.49B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $800.00K; Retained Earnings (Accumulated Deficit)USD $-1.12B.
- 2025-09-30: Common Stock, Value, IssuedUSD $900.00K; Additional Paid in Capital, Common StockUSD $1.49B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-100.00K; Retained Earnings (Accumulated Deficit)USD $-1.11B.
MYRIAD GENETICS, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD | Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.00M | $1.50B | $800.00K | $-1.20B | $303.90M | 3 month · $7.20M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $900.00K | $1.49B | $700.00K | $-1.16B | $337.40M | 3 month · $6.50M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $900.00K | $1.49B | $800.00K | $-1.12B | $368.00M | 12 month · $35.20M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $900.00K | $1.49B | $-100.00K | $-1.11B | $372.80M | 3 month · $12.20M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $900.00K | $1.47B | $-100.00K | $-1.09B | $388.10M | 3 month · $10.70M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $900.00K | $1.46B | $-600.00K | $-756.90M | $704.90M | 3 month · $9.50M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $900.00K | $1.46B | $-800.00K | $-756.80M | $701.10M | 12 month · $49.80M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $900.00K | $1.45B | $-100.00K | $-714.30M | $731.70M | 3 month · $12.40M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $900.00K | $1.44B | $-4.00M | $-692.20M | $740.50M | 3 month · $14.50M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $900.00K | $1.42B | $-4.20M | $-655.50M | $760.00M | 3 month · $12.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $900.00K | $1.42B | $-3.70M | $-629.50M | $783.20M | 12 month · $40.70M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $800.00K | $1.29B | $-5.30M | $-598.30M | $683.40M | 3 month · $11.60M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $800.00K | $1.28B | $-5.40M | $-537.00M | $735.20M | 3 month · $11.20M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $800.00K | $1.26B | $-7.40M | $-420.90M | $835.20M | 3 month · $7.50M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $800.00K | $1.26B | $-8.90M | $-366.20M | $885.80M | 12 month · $38.10M | (m) | $-6.20M | (m) | $885.80M | (m) | (m) |
| 2022-09-30 | $800.00K | $1.25B | $-11.30M | $-323.90M | $916.60M | 3 month · $9.40M | (m) | (m) | (m) | $916.60M | (m) | (m) |
| 2022-06-30 | $800.00K | $1.24B | $-8.90M | $-288.80M | $947.40M | 3 month · $10.40M | (m) | (m) | (m) | $947.40M | (m) | (m) |
| 2022-03-31 | $800.00K | $1.23B | $-7.60M | $-274.70M | $950.10M | 3 month · $10.10M | (m) | (m) | (m) | $950.10M | (m) | (m) |
| 2021-12-31 | $800.00K | $1.23B | $-5.10M | $-254.20M | $967.80M | 12 month · $36.50M | (m) | $-4.90M | (m) | $967.80M | (m) | (m) |
| 2021-09-30 | $800.00K | $1.22B | $-4.40M | $-246.60M | $968.60M | 3 month · $10.00M | (m) | (m) | (m) | $968.50M | (m) | (m) |
| 2021-06-30 | $800.00K | $1.18B | $-4.00M | $-271.20M | $902.50M | 3 month · $8.90M | (m) | (m) | (m) | $902.40M | (m) | (m) |
| 2021-03-31 | $800.00K | $1.14B | $-3.60M | $-266.50M | $875.20M | 3 month · $9.00M | (m) | (m) | (m) | $875.20M | (m) | (m) |
| 2020-12-31 | $800.00K | $1.11B | $-2.30M | $-227.00M | $881.00M | 6 month · $14.90M | (m) | $-3.10M | (m) | $881.00M | (m) | (m) |
| 2020-09-30 | $800.00K | $1.10B | $-3.60M | $-189.10M | $909.30M | 3 month · $8.40M | (m) | (m) | (m) | $909.30M | (m) | (m) |
| 2020-06-30 | $700.00K | $1.10B | $-5.20M | $-173.90M | $918.20M | 3 month · $1.90M 12 month · $25.20M | (m) | $-6.50M | (m) | $918.20M | (m) | (m) |
| 2020-03-31 | $700.00K | $1.09B | $-7.80M | $-118.50M | $967.20M | 3 month · $7.50M | (m) | (m) | (m) | $967.20M | (m) | (m) |
| 2019-12-31 | $700.00K | $1.09B | $-5.30M | $-3.30M | $1.08B | 3 month · $7.00M | (m) | (m) | (m) | $1.08B | (m) | (m) |
| 2019-09-30 | $700.00K | $1.08B | $-7.50M | $5.00M | $1.07B | 3 month · $8.80M | (m) | (m) | (m) | $1.07B | (m) | (m) |
| 2019-06-30 | $700.00K | $1.07B | $-5.40M | $25.60M | $1.09B | 12 month · $33.50M | (m) | $-7.20M | (m) | $1.09B | (m) | (m) |
| 2019-03-31 | $700.00K | $1.06B | $-5.70M | $29.80M | $1.08B | 3 month · $9.50M | (m) | (m) | (m) | $1.08B | (m) | (m) |
| 2018-12-31 | $700.00K | $1.05B | $-5.00M | $22.90M | $1.06B | 3 month · $7.50M | (m) | (m) | (m) | $1.06B | (m) | (m) |
| 2018-09-30 | $700.00K | $1.05B | $-4.30M | $53.40M | $1.10B | 3 month · $7.70M | (m) | (m) | (m) | $1.10B | (m) | (m) |
| 2018-06-30 | $700.00K | $915.40M | $-4.10M | $54.10M | $966.10M | 12 month · $27.10M | (m) | $-4.10M | (m) | $966.10M | (m) | (m) |
| 2018-03-31 | $700.00K | $889.60M | $1.80M | $56.20M | $948.30M | 3 month · $6.60M | (m) | (m) | (m) | $932.80M | (m) | (m) |
| 2017-12-31 | $700.00K | $871.10M | $-2.40M | $44.80M | $914.20M | 3 month · $6.90M | (m) | (m) | (m) | $900.90M | (m) | (m) |
| 2017-09-30 | $700.00K | $859.60M | $-2.20M | $12.80M | $870.90M | 3 month · $6.40M | (m) | (m) | (m) | $858.40M | (m) | (m) |
| 2017-06-30 | $700.00K | $851.40M | $-5.50M | $-79.20M | $768.40M | 12 month · $29.90M | (m) | $-5.70M | (m) | $767.40M | (m) | 12 month · $3.10M |
| 2017-03-31 | $700.00K | $839.50M | $-10.60M | $-81.40M | $748.20M | (m) | (m) | (m) | (m) | $747.90M | (m) | (m) |
| 2016-12-31 | $700.00K | $831.80M | $-13.90M | $-85.70M | $732.90M | (m) | (m) | (m) | (m) | $732.70M | (m) | (m) |
| 2016-09-30 | $700.00K | $826.90M | $-5.60M | $-86.50M | $735.50M | (m) | (m) | (m) | (m) | $735.30M | (m) | (m) |
| 2016-06-30 | $700.00K | $830.10M | $-9.50M | $-73.20M | $739.60M | 12 month · $31.60M | (m) | $-10.10M | (m) | $741.70M | 12 month · $12.70M | (m) |
| 2016-03-31 | $700.00K | $847.00M | $-8.30M | $-69.20M | $770.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $700.00K | $847.80M | $-9.10M | $-68.60M | $770.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | $700.00K | $772.30M | $-7.10M | $-78.80M | $687.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | $700.00K | $745.40M | $-7.00M | $-77.00M | $661.70M | 12 month · $45.70M | $745.40M | $-7.00M | (m) | (m) | 12 month · $3.40M | (m) |
| 2015-03-31 | $700.00K | (m) | $-7.56M | $-62.28M | $668.90M | (m) | $738.04M | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $719.00K | (m) | $-4.18M | $-36.98M | $694.24M | (m) | $734.68M | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | $729.00K | (m) | $-2.37M | $-17.45M | $712.15M | (m) | $731.24M | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | $700.00K | (m) | $-1.50M | $2.00M | $719.00M | 12 month · $27.10M | $717.80M | $-1.80M | (m) | (m) | 12 month · $11.10M | (m) |
| 2014-03-31 | $745.00K | (m) | $-122.00K | $18.86M | $722.24M | (m) | $702.75M | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $740.00K | (m) | $506.00K | $11.60M | $675.97M | (m) | $663.12M | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | $768.00K | (m) | $365.00K | $13.96M | $690.27M | (m) | $675.18M | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | $806.00K | (m) | $-424.00K | $30.87M | $728.60M | 12 month · $26.60M | $697.35M | (m) | (m) | (m) | 12 month · $7.90M | (m) |
| 2013-03-31 | $797.00K | (m) | $-459.00K | $2.05M | $664.93M | (m) | $662.54M | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $813.00K | (m) | $-221.00K | $-4.27M | $662.12M | (m) | $665.80M | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | $814.00K | (m) | $129.00K | $-15.00M | $635.57M | (m) | $649.62M | $208.00K | $83.00K | (m) | (m) | (m) |
| 2012-06-30 | $826.00K | (m) | $-162.00K | $-12.68M | $635.80M | 12 month · $26.27M | $647.68M | (m) | (m) | (m) | 12 month · $34.19M | (m) |
| 2012-03-31 | $845.00K | (m) | $-99.00K | $-88.00K | $652.19M | (m) | $651.53M | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $842.00K | (m) | $-253.00K | $-21.43M | $616.76M | (m) | $637.61M | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | $846.00K | (m) | $-113.00K | $-38.30M | $578.99M | (m) | $616.56M | $-123.00K | $-141.00K | (m) | (m) | (m) |
| 2011-06-30 | $862.00K | (m) | $151.00K | $-38.63M | $566.79M | 12 month · $25.09M | $604.41M | (m) | (m) | (m) | 12 month · $58.83M | (m) |
| 2011-03-31 | $857.00K | (m) | $100.00K | $-48.08M | $524.46M | (m) | $571.59M | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $901.00K | (m) | $99.00K | $-20.66M | $561.10M | (m) | $580.76M | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | $924.00K | (m) | $262.00K | $-3.76M | $571.11M | (m) | $573.68M | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | $940.00K | (m) | $139.00K | $-10.46M | $557.58M | 12 month · $22.78M | $566.97M | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | $434.22M | 12 month · $25.68M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) | $425.65M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |